EE200200246A - Epinastiini sisaldavad lahused - Google Patents

Epinastiini sisaldavad lahused

Info

Publication number
EE200200246A
EE200200246A EEP200200246A EEP200200246A EE200200246A EE 200200246 A EE200200246 A EE 200200246A EE P200200246 A EEP200200246 A EE P200200246A EE P200200246 A EEP200200246 A EE P200200246A EE 200200246 A EE200200246 A EE 200200246A
Authority
EE
Estonia
Prior art keywords
solutions containing
containing epinastine
epinastine
solutions
Prior art date
Application number
EEP200200246A
Other languages
English (en)
Inventor
Trach Volker
Duschler Gerold
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200246(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of EE200200246A publication Critical patent/EE200200246A/et
Publication of EE05395B1 publication Critical patent/EE05395B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
EEP200200246A 1999-11-12 2000-10-14 Epinastiini sisaldavad lahused EE05395B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (2)

Publication Number Publication Date
EE200200246A true EE200200246A (et) 2003-06-16
EE05395B1 EE05395B1 (et) 2011-04-15

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200246A EE05395B1 (et) 1999-11-12 2000-10-14 Epinastiini sisaldavad lahused

Country Status (40)

Country Link
US (6) US20030050303A1 (et)
EP (1) EP1231920B1 (et)
JP (1) JP2003514021A (et)
KR (1) KR100758842B1 (et)
CN (1) CN1292752C (et)
AR (1) AR026424A1 (et)
AT (1) ATE353218T1 (et)
AU (2) AU784017B2 (et)
BG (1) BG65775B1 (et)
BR (1) BR0015477A (et)
CA (1) CA2391076C (et)
CO (1) CO5251448A1 (et)
CY (1) CY1106375T1 (et)
CZ (1) CZ302483B6 (et)
DE (2) DE19954516A1 (et)
DK (1) DK1231920T3 (et)
EA (1) EA006937B1 (et)
EE (1) EE05395B1 (et)
ES (1) ES2281359T3 (et)
HK (1) HK1052303B (et)
HR (1) HRP20020404B1 (et)
HU (1) HU229502B1 (et)
IL (2) IL149501A0 (et)
ME (1) MEP36708A (et)
MX (1) MXPA02004556A (et)
MY (1) MY130441A (et)
NO (1) NO329417B1 (et)
NZ (1) NZ519425A (et)
PE (1) PE20010826A1 (et)
PL (1) PL198879B1 (et)
PT (1) PT1231920E (et)
RS (1) RS50173B (et)
SA (1) SA01210658B1 (et)
SI (1) SI1231920T1 (et)
SK (1) SK287343B6 (et)
TR (1) TR200201270T2 (et)
TW (1) TWI225401B (et)
UA (1) UA74563C2 (et)
WO (1) WO2001035962A1 (et)
ZA (1) ZA200203683B (et)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
WO2007007851A1 (en) * 2005-07-08 2007-01-18 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
US20120203161A1 (en) * 2009-08-12 2012-08-09 Seros Medical, Llc Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method of use
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
US11058677B2 (en) * 2012-12-19 2021-07-13 Novartis Ag LFA-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
KR20230136703A (ko) * 2017-05-01 2023-09-26 산텐 세이야꾸 가부시키가이샤 점안제
JP2019108320A (ja) * 2018-10-31 2019-07-04 参天製薬株式会社 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US228359A (en) * 1880-06-01 jones
US215396A (en) * 1879-05-13 Improvement in loom-temples
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US8632A (en) * 1852-01-06 George hess
US181478A (en) * 1876-08-22 Improvement in water-wheels
US151541A (en) * 1874-06-02 Improvement in hay-loaders
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
KR100392280B1 (ko) * 1995-06-27 2003-11-19 베링거 인겔하임 카게 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
EP0937457A4 (en) * 1996-08-30 2000-09-27 Kyoto Pharma Ind MEDICINE AGAINST ALLERGIC DERMATITIS
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
BR0015647A (pt) * 1999-11-18 2002-07-16 Alcon Inc Uso de um antagonista de h1 e um esteróide seguro para tratar condições dos olhos
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
NO329417B1 (no) 2010-10-18
BR0015477A (pt) 2002-06-25
WO2001035962A1 (de) 2001-05-25
HU229502B1 (en) 2014-01-28
SK287343B6 (sk) 2010-07-07
US20090239842A1 (en) 2009-09-24
ATE353218T1 (de) 2007-02-15
SI1231920T1 (sl) 2007-06-30
JP2003514021A (ja) 2003-04-15
AR026424A1 (es) 2003-02-12
BG65775B1 (bg) 2009-11-30
EP1231920B1 (de) 2007-02-07
YU33602A (sh) 2005-03-15
CN1390129A (zh) 2003-01-08
AU1138101A (en) 2001-05-30
US20050288274A1 (en) 2005-12-29
US20030050303A1 (en) 2003-03-13
PL198879B1 (pl) 2008-07-31
ES2281359T3 (es) 2007-10-01
DE19954516A1 (de) 2001-05-17
HK1052303B (zh) 2007-04-13
AU2006201541A1 (en) 2006-05-11
DE50014041D1 (de) 2007-03-22
MXPA02004556A (es) 2004-09-10
PT1231920E (pt) 2007-03-30
US7429602B2 (en) 2008-09-30
CA2391076C (en) 2008-06-17
CO5251448A1 (es) 2003-02-28
ZA200203683B (en) 2003-09-03
RS50173B (sr) 2009-05-06
CZ20021956A3 (cs) 2002-08-14
CY1106375T1 (el) 2011-10-12
CN1292752C (zh) 2007-01-03
TR200201270T2 (tr) 2002-12-23
NO20022201L (no) 2002-05-08
IL149501A (en) 2012-04-30
PL364028A1 (en) 2004-11-29
UA74563C2 (uk) 2006-01-16
CZ302483B6 (cs) 2011-06-08
EP1231920A1 (de) 2002-08-21
CA2391076A1 (en) 2001-05-25
US20080009476A1 (en) 2008-01-10
PE20010826A1 (es) 2001-08-20
HRP20020404B1 (en) 2007-08-31
BG106681A (en) 2002-12-29
NZ519425A (en) 2004-04-30
KR20020050273A (ko) 2002-06-26
HUP0203773A3 (en) 2005-01-28
IL149501A0 (en) 2002-11-10
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
KR100758842B1 (ko) 2007-09-19
MY130441A (en) 2007-06-29
DK1231920T3 (da) 2007-04-10
SK8302002A3 (en) 2002-09-10
AU784017B2 (en) 2006-01-12
EA006937B1 (ru) 2006-06-30
EE05395B1 (et) 2011-04-15
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
SA01210658B1 (ar) 2006-11-05
US20070185082A1 (en) 2007-08-09
HK1052303A1 (en) 2003-09-11
MEP36708A (en) 2011-02-10
US20070197503A1 (en) 2007-08-23
EA200200492A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20022201D0 (no) Lösninger inneholdende Epinastin
NO2008005I1 (no) Trabectedin
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
DE60039942D1 (de) Selbstbräununsschaum
NO20022871D0 (no) Organometallsammensetningskatalysator
DE60014431D1 (de) Bleichmittel
DE60025647D1 (de) Festkörperbildaufnahemvorrichtung
DE60008638D1 (de) Förderbandabstreicher
MA26850A1 (fr) 4-pyrimidinyle- n- acyl- l- phenylalanines
FI4231U1 (fi) Kotelo
ATE319461T1 (de) Simethicon enthaltendes abführmittel
NO20020278D0 (no) Fosfattransportinhibitorer
DE29905172U1 (de) Handprogrammer
DE50015451D1 (de) Spülwannensystem
ID26898A (id) Serat hidrofilik
ITMO990105A0 (it) Occhiali
DE69935205D1 (de) Unterbrechungssteurerungssystem
DE60011488D1 (de) Tuftinggarnauswahlorgan
NO20015644L (no) Polarisasjonssepareringsfilter
DE60033215D1 (de) Farbband
NO20005774L (no) Leketöyanordning
FI19991829A (fi) Uintianalysaattori
DE60006044D1 (de) Drehgeschwindigkeitsaufnehmer
NO20014261D0 (no) Histidinproteinfosfatase
ATA121799A (de) Ausbeulgerät